Evidence map›Paper›PMID 41151579›Full record

ArticleCell reports. Medicine2025

Ribosome dysregulation and intervention in age-related infertility.

Jie Li, Honghong Wang, Pengfei Zhu, Haixia Chen, Haiyang Zuo, Chang Liu, Linlin Liu, Xiaoying Ye, Guofeng Feng, Yiwei Wu and 7 more

Abstract read
In one paragraph

Article in Cell reports. Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The role of mTOR signaling in regulating the quality of mammalian oocytes.Journal of assisted reproduction and genetics · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jie LiState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Honghong WangCenter for Reproductive Medicine, Children's Hospital of Shanxi and Women Health Center of Shanxi, Taiyuan 030013, China; Shanxi Center of Technology Innovation for Fertility Optimization, Taiyuan 030001, Shanxi, China.
Pengfei ZhuCenter for Reproductive Medicine, Children's Hospital of Shanxi and Women Health Center of Shanxi, Taiyuan 030013, China; Shanxi Center of Technology Innovation for Fertility Optimization, Taiyuan 030001, Shanxi, China.
Haixia ChenCenter for Reproductive Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China.
Haiyang ZuoDepartment of Obstetrics and Gynecology, The Sixth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing 100142, China.
Chang LiuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Linlin LiuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Xiaoying YeState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Guofeng FengState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Yiwei WuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Qinli LiuReproductive Medical Center, Amcare Women's & Children's Hospital, Tianjin 300381, China.
Tao YangHigher Education Key Laboratory of Tumor Immunology & Targeted Drug Development in Shanxi Province, Shanxi Medical University, Taiyuan 030001, Shanxi, China; Department of Biochemistry & Molecular Biology, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
David L KeefeDepartment of Obstetrics and Gynecology, NYU Langone Health, 550 First Avenue, New York, NY 10012, USA.
Xiaohong BaiCenter for Reproductive Medicine, Tianjin Medical University General Hospital, Tianjin 300052, China. Electronic address: bxhjj@163.com.
Wei ShangDepartment of Obstetrics and Gynecology, The Sixth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing 100142, China. Electronic address: shang.wei@163.com.
Xueqing WuCenter for Reproductive Medicine, Children's Hospital of Shanxi and Women Health Center of Shanxi, Taiyuan 030013, China; Shanxi Center of Technology Innovation for Fertility Optimization, Taiyuan 030001, Shanxi, China. Electronic address: wuxueqq@hotmail.com.
Lin LiuState Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, China; Department of Cell Biology and Genetics, Nankai University, 94 Weijin Road, Tianjin 300071, China; Institute of Translational Medicine, Tianjin Union Medical Center, Nankai University, Tianjin 300000, China. Electronic address: liulin@nankai.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fertility in women decreases with age, but the molecular basis for age-related, unexplained infertility remains elusive. Here, we reveal distinct transcriptome changes in oocytes and surrounding cumulus cells from women in their mid-thirties, as evidenced by notably increased transcription of ribosome genes. Additionally, meiosis genes and actin and cohesin components are downregulated in oocytes with age. Lysosomes and proteostasis are also disrupted in cumulus cells. Moreover, DNA hypomethylation and altered heterochromatin deposition at specific genomic loci are linked to increased transcription of ribosome genes. Rapamycin effectively reduces translation and promotes protein homeostasis in cumulus cells. Remarkably, short-term rapamycin allows patients who fail repeated in vitro fertilization cycles with embryo developmental arrest to achieve high-quality blastocysts that yield successful pregnancy and live birth. These data suggest a causal role for elevated transcription of ribosome genes in aging oocytes and cumulus cells and identify rapamycin as a promising treatment for age-related infertility. This study is registered at Chinese Clinical Trial Registry (ChiCTR2300069828).

Indexed as

AgingInfertility, FemaleRibosomesAdultCumulus CellsDNA MethylationFemaleFertilization in VitroHumansMeiosisOocytesPregnancySirolimusTranscriptomeSirolimusagingcumulus cellsinfertilityoocyterapamycinribosome

Identifiers

PMID41151579
PMCPMC12711675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.